Curaleaf Holdings, Inc. (CURLF)
2.42
+0.04
(+1.68%)
USD |
OTCM |
Feb 13, 16:00
Curaleaf Holdings EPS Diluted (Quarterly) : -0.0746 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tilray Brands, Inc. | -0.4072 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.55M |
| Revenue (Quarterly) | 320.24M |
| Total Expenses (Quarterly) | 375.14M |
| Enterprise Value | 2.854B |
| Gross Profit Margin (Quarterly) | 38.88% |
| Profit Margin (Quarterly) | -17.03% |
| Earnings Yield | -14.39% |
| Operating Earnings Yield | 0.32% |
| Normalized Earnings Yield | -12.17 |